Analysts’ View: Haemonetics (HAE), ON Semiconductor (ON), Tesla (TSLA)

Investment Analysts at Barrington Research upgraded Haemonetics Corp. (NYSE:HAE) shares from Market Perform to Outperform rating with a price target of $48.

Haemonetics Corp. operates as a global healthcare company, which engages in the provision of products for processing, handling, and analysis of blood.


Brokerage Firm Needham upgraded ON Semiconductor Corp.(NASDAQ:ON) shares from Buy to Strong Buy rating while increasing their price target from $20 to $25.

ON Semiconductor Corp. is a supplier of silicon solutions for energy electronics, which engages in the design, manufacture, and market portfolio of semiconductor components that address the design needs of electronic systems and products.


Tesla Inc. (NASDAQ:TSLA) shares were upgraded by analysts at Argus from Hold to Buy rating with a price target of $444.

Tesla, Inc. engages in the designing, development, manufacturing and sale of electric vehicles and electric power train components.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at